SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma

A growing number of evidence have demonstrated the involvement of enhancer RNAs (eRNAs) in tumor progression.However, the possible functions of eRNAs in hepatocellular carcinoma (HCC) remain largely unclear.Our present research jetstream ice therapy parts aimed to screen critical eRNAs and to further delve into the clinical significance of eRNAs in

read more

Tax treatment of status change of commercial companies

The aim of this article is to give a comprehensive overview of tax responsibility of a commercial company undergoing status change.Having in mind the frequency of status changes of commercial companies in Serbia, this is a mermaid cocktail set very important position from which to examine the complex process of status change.Because of that provisi

read more